67
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease

, , , , , & show all
Pages 375-388 | Published online: 26 Jul 2011

References

  • WilliamsDMBourdetSVChronic obstructive pulmonary diseaseDiPiroJTTalbertRYeeGPharmacotherapy: A Pathophysiologic Approach7th edNew York, NYMcGraw Hill Medical2008495517
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of COPD Updated December 2009. Available from: http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=2003. Accessed May 6, 2011.
  • National Heart, Lung and Blood InstituteChronic obstructive pulmonary disease: data Fact SheetBethesdaUS Department of Health and Human Services. National Institutes of Health NIH Publication No. 03-5529;2003
  • ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000MMWR Surveill Summ2002516116
  • National Heart, Lung and Blood InstituteCOPD Fact SheetBethesdaUS Department of Health and Human Services. National Institutes of Health NIH Publication No. 03-5229;32003
  • National Heart, Lung and Blood InstituteMorbidity and Mortality: 2007 Chart Book on Cardiovascular, Lung and Blood DisordersNational Institutes of Health62007
  • HananiaNAThe impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPDPulm Pharmacol Ther200821354055018280761
  • GrossNLevinDPrimary care of the patient with chronic obstructive pulmonary disease part 2: pharmacologic treatment across all stages of diseaseAm J Med2008121Suppl 7S13S2418558103
  • FosterJAYawnBPMaziarAJenkinsTRennardSICasebeerLEnhancing COPD management in primary care settingsMedGenMed2007932418092030
  • DietteGBOrrPMcCormackMCGandyWHamarBIs pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines?Popul Health Manag2010131212620158320
  • RamseySDSuboptimal medical therapy in COPD: exploring the causes and consequencesChest2000117Suppl 233S37S10673472
  • DeleaTEStanfordRHHagiwaraMStempelDAAssociation between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costsCurr Med Res Opin200824123435344219032125
  • RandCSPatient adherence with COPD therapyEur Respir Rev20051497101
  • BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
  • KrigsmanKNilssonLGRingLRefill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptionsPharmacoepidemiol Drug Saf200716444144817006959
  • GeorgeJKongDCMThomanRStewartKFactors associated with medication non-adherence in patients with COPDChest200512853198320416304262
  • JungEPickardASSalmonJWBartleBLeeTAMedication adherence and persistence in the last year of life in COPD patientsRespir Med2009103452553419136240
  • DeleaTEHagiwaraMDalalAAStanfordRHBlanchetteCMHealthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapiesCurr Med Res Opin200925111319210134
  • DolceJJCrispCManzellaBRichardsJMHardinJMBaileyWCMedication adherence patterns in chronic obstructive pulmonary diseaseChest19919948378412009784
  • RandCSNidesMCowlesMKWiseRAConnettJLong-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research GroupAm J Respir Crit Care Med199515225805887633711
  • RandCSWiseRANidesMMetered-dose inhaler adherence in a clinical trialAm Rev Respir Dis19921466155915641456575
  • BalkrishnanRChristensenDBInhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary diseaseClin Ther200022445246910823366
  • DiMatteoMRVariations in patients’ adherence to medical recommendations: a quantitative review of 50 years of researchMed Care200442320020915076819
  • FusoLIncalziRAPistelliRPredicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary diseaseAm J Med19959832722777872344
  • Garcia-AymerichJBarreiroEFarreroEMarradesRMMoreraJAntóJMPatients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study)Eur Respir J20001661037104211292102
  • SinDDMcAlisterFAManSFAnthonisenNRContemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA2003290172301231214600189
  • SchmierJKHalpernMTJonesMLEffects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidenceDrugs Aging200522971772916156676
  • AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf200615856557416514590
  • SikkaRXiaFAubertREEstimating medication persistency using administrative claims dataAm J Manag Care200511744945716044982
  • ChrischillesEGildenDKubisiakJRubensteinLShahHDelivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalersAm J Manag Care200281090291112395958
  • Comorbidity software: version 3.2 Available from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed March 4, 2011.
  • QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
  • DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • ManningWGMullahyJEstimating log models: to transform or not to transform?J Health Econ200120446149411469231
  • GlaxoSmithKlineHighlights of prescribing information for Advair Diskus Revised June 2010. Available online at: http://us.gsk.com/products/assets/us_advair.pdf. Accessed March 4, 2011.
  • Boehringer Ingelheim Pharmaceuticals, IncHighlights of prescribing information for Spiriva® HandiHaler® Revised June 2010. Available online at: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewS-ervlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Spiriva/Spiriva.pdf. Accessed March 4, 2011.
  • JansonCDe MarcoRAccordiniSChanges in the use of anti-asthmatic medication in an international cohortEur Respir J20052661047105516319334
  • CazzolaMMateraMGNovel long-acting bronchodilators for COPD and asthmaBr J Pharmacol2008155329129918604231